Recomp Complete
The Recomp pair, with monthly female hormone therapy reviewed alongside it.
Tirzepatide weekly, sermorelin nightly, and daily estradiol with micronized progesterone on the monthly plan. One clinician reviews all three together, which is the reason to buy them together rather than separately.
$637 / month
Payment is collected before clinical review. GEN displays the total due today at checkout. A prescription is not guaranteed. Questions about payment after review? Email hello@get-the-standard.com.
Each compound, on its own schedule.
Dual GLP-1 / GIP receptor agonist. Titrated from the starting dose on clinician judgment.
Full spec sheet →GHRH 1-29 fragment, dosed at night to sit with the body's own overnight release.
Full spec sheet →Estradiol with micronized progesterone. Strength is titrated by the prescriber at consultation.
Full spec sheet →The protocol price is the sum of its compounds at their individual monthly prices — $637 / month. Buying them together puts them in front of one clinician in one review; it is not a discount.
What you are paying for.
A protocol is a prescription plan, not a product you add to a cart. Read these before you pay.
- 01Hormone therapy, not testosterone
The hormone component of this protocol is estradiol with micronized progesterone. It is not testosterone and not a women's T protocol — those are separate prescriptions and are not included here.
- 02Three prescriptions, one review
All three compounds are reviewed together by one licensed clinician, and any one can be declined on its own. Questions about payment after review? Email hello@get-the-standard.com.
- 03Hormone therapy needs a visit
The hormone component requires a telehealth visit before it can be written. Your clinician schedules it as part of onboarding; the other two compounds are reviewed asynchronously.
- 04Compounded to order
Every compound is prepared by a 503A or 503B partner pharmacy against your written prescription, and third-party tested for sterility, endotoxin load and potency before release.